A Randomized, Double-Blind, Crossover Comparative Endoscopy Study on the Gastroduodenal Tolerability of a Highly Specific Cyclooxygenase-2 Inhibitor, Flosulide, and Naproxen

References

• Barrier C H, Hirschowitz BI. Current controversies in rheumatology. Controversies and management of non-steroidal anti-inflammatory drug induced side effects on upper gastrointestinal tract. Arthritis Rheum 1989; 32: 926–9
   PubMed Web of Science ®Google Scholar
• Armstrong C P, Blower AL. Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulcer disease. Gut 1987; 28: 527–32
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Macpherson A J, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 1993; 104: 1832–47
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Hayllar J, Rafi S, Wrigglesworth J, Macpherson A, Bjarnason I. The biochemical basis of induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 1995; 30: 289–99
   PubMed Web of Science ®Google Scholar
• Wallace JL. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined. Scand J Gastroenterol 1992; 27: 3–8, Suppl 192
   Web of Science ®Google Scholar
• Wallace J L, Granger DM. Pathogenesis of NSAID gastropathy: are neutrophils the culprits. Trends Pharmacol Sci 1992; 13: 129–30
   PubMed Web of Science ®Google Scholar
• Whittle B JR. Protective mechanisms of the gastric mucosa. The stomach, S Gustsavsson, D Kumar, DY Graham. Churchill Livingstone, Edinburgh 1992; 81–101
   Google Scholar
• Rainsford KD. Mechanisms of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 1989; 24: 9–16, Suppl 163
   PubMed Web of Science ®Google Scholar
• Hayllar J, Macpherson A, Bjarnason I. Gastroprotection and nonsteroidal anti-inflammatory drugs. Drug Safety 1992; 7: 86–105
   PubMed Web of Science ®Google Scholar
• Fern GC. Controversies in NSAID-induced gastroduodenal damage-do they matter. Aliment Pharmacol Ther 1994; 8: 15–26
   PubMed Web of Science ®Google Scholar
• Wallace J L, Reuter B, Cicala C, McKnight W, Grisham M B, Cirino GA. A diclofenac derivative without ulcerogenic properlies. Eur J Pharmacol 1994; 257: 249–55
   PubMed Web of Science ®Google Scholar
• Wallace J L, Reuter B, Cicala C, McKnight W, Grisham M B, Cirino G. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in rat. Gastroenterology 1994; 107: 173–9
   PubMed Web of Science ®Google Scholar
• Simmons D, Xie W, Evett G, Merrill J, Robertson D L, Bradshaw WS. Drug inhibition and cellular regulation of prostaglandin G/H synthase isoenzyme 2. J Lipid Med 1993; 6: 113–7
   PubMedGoogle Scholar
• Herschman H, Fletcher B, Kujubu D. TIS10. A mitogen-inducible glucocorticoid-inhibited gene that encodes a second prostaglandin synthase/cyclooxygenase enzyme. J Lipid Med 1993; 6: 89–99
   PubMedGoogle Scholar
• Mitchell J A, Akarasereenout P, Thiemermann C, Flower R J, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693–7
   PubMed Web of Science ®Google Scholar
• O'Neill G P, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cycloozygenase-2 in human tissues. FEBS 1993; 330: 156–60
   PubMed Web of Science ®Google Scholar
• Morham S G, Langenbach R, Loftin C D, Tiano H F, Vouloumanos N, Jennette J C. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83: 473–82
   PubMed Web of Science ®Google Scholar
• Maier J A, Hla T, Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin 1 in human endothelial cell. J Biol Chem 1992; 265: 10805–8
   Web of Science ®Google Scholar
• Lee S H, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267: 25934–8
   PubMed Web of Science ®Google Scholar
• Vane JR. Towards a better aspirin. Nature 1994; 367: 215–6
   PubMed Web of Science ®Google Scholar
• Hayllar J, Bjarnason I. NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995; 346: 521–2
   PubMed Web of Science ®Google Scholar
• Vane J R, Botting RM. Overview-mechanisms of action of anti-inflammatory drugs. Improved non-steroid anti-inflammatory drugs. Cox-2 enzyme inhibitors, JR Vane, J Botting, R Botting. Kluwer Academic Publishers, Dordrecht 1996; 1–27
   Google Scholar
• Meade E A, Smith W L, DeWitl DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1995; 68: 6610–4
   Google Scholar
• Vane JR. NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995; 346: 1105–6
   PubMedGoogle Scholar
• Aslanian R, Carruthers N I, Kaminski J. Cyclooxygenase-2: a novel target for therapeutic intervention. Exp Opin Invest Drugs 1994; 3: 1323–5
   Google Scholar
• Wiesenberg-Boeettcher I, Schweizer A, Muller K. The pharmacologic profile of CGP 28238, a highly potent anti-inflammatory compound. Agents Actions 1989; 26: 240–2
   PubMedGoogle Scholar
• Wiesenberg-Boeettcher I, Schweizer A, Muller K, Maerki F, Pfeilschifter J. The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound. Drug Exp Clin Res 1989; 15: 501–9
   Google Scholar
• Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 1984; 77: 19–24, Suppl 1 A
   PubMed Web of Science ®Google Scholar
• Lanza F L, Graham D Y, Davis R E, Rack MF. Endoscopic evaluation of cimethidine and sucralfate for prevention of naproxen-induced gastroduodenal injury: effects of scoring method. Dig Dis Sci 1990; 35: 1494–9
   PubMed Web of Science ®Google Scholar
• Farkad E, Whitehead J. Statistics in medicine 1991; 10: 901–7
   PubMed Web of Science ®Google Scholar
• Klein T, Nusing R M, Pfeilschifter J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994; 48: 1605–10
   PubMed Web of Science ®Google Scholar
• Bardhan K D, Bjarnason 1, Scott D L, Griffin W M, Fenn G C, Shield M J. The prevention and healing of acute NSAID-associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol 1993; 32: 990–5
   PubMedGoogle Scholar
• Giercksky K E, Huseby G, Rugstad HE. Epidemiology of NSAID-related gastrointestinal side effects. Scand J Gastroenterol 1989; 24: 3–8, Suppl 163
   Web of Science ®Google Scholar
• Rodrigues L AG, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769–72
   PubMed Web of Science ®Google Scholar
• Langman M JS, Weil J, Wainwright P, Lawson D H, Rawlins M D, Logan R FA. Risk of bleeding peptic ulcers associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–8
   PubMed Web of Science ®Google Scholar
• Lanza F L, Rack M F, Lynn M, Wolf B S, Sanda M. An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen and placebo on the gastrointestinal mucosa. J Rheumatol 1987; 14: 338–41
   PubMed Web of Science ®Google Scholar
• Trondstad R I, Aadland E, Holler T, Olaussen B. Gastroscopic findings after treatment with enteric coated and plain naproxen tablets in healthy subjects. Scand J Gastroenterol 1985; 20: 239–42
   PubMed Web of Science ®Google Scholar
• Mahmod T, Rafi S, Scott D, Wrigglesworth J M, Bjarnason I. NSAIDs and uncoupling of mitochondrial oxidative phosphorylation. Arth Rheumat 1996, In press
   Google Scholar